Skip to main content
SpringerLink
Log in

Editorial „Statintherapie“

  • Themenschwerpunkt „Statintherapie“
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002:360:7–22.

    Article  Google Scholar 

  2. Sacks FM. Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L. warnica JW, Arnold JM, Wun CC. Davis BR. Braunwald E for the Cholesterol and Recurrent Events Trial Investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001–1009.

    Article  PubMed  CAS  Google Scholar 

  3. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–1389.

    Google Scholar 

  4. Serruys PWJC, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, Branzi A, Bertolami MC, Jackson G, Strauss B, Meier B for the Lescol Intervention Prevention Study (LIPS) Investigators: Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomised controlled trial. JAMA 2002:287:3215–3222.

    Article  PubMed  CAS  Google Scholar 

  5. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, MacFarlane PW, Meinders AE, Nome J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG on behalf of the PROSPER study group: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623–1630.

    Article  PubMed  CAS  Google Scholar 

  6. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ for the West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301–1307.

    Article  PubMed  CAS  Google Scholar 

  7. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349–1357.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gesellschaft für klinische Pharmakologie, Kinderspitalgasse 10/15,,A-1090, Wien

    Gerhart Hitzenberger

Authors
  1. Gerhart Hitzenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerhart Hitzenberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hitzenberger, G. Editorial „Statintherapie“. WMW 153, 242–243 (2003). https://doi.org/10.1046/j.1563-258X.2003.03027.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1046/j.1563-258X.2003.03027.x

Search

Navigation